The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation
Abstract
We report here on a preliminary human autologous transplantation study of retroviral gene transfer to bone marrow (BM) and peripheral blood (PB)-derived CD34-enriched cells. Eleven patients with multiple myeloma or breast cancer had cyclophosphamide and filgrastim-mobilized PB cells CD34-enriched and transduced with a retroviral marking vector containing the neomycin resistance gene, and CD34-enriched BM cells transduced with a second marking vector also containing a neomycin resistance gene. After high-dose conditioning therapy, both transduced cell populations were reinfused and patients were followed over time for the presence of the marker gene and any adverse effects related to the gene-transfer procedure. All 10 evaluable patients had the marker gene detected at the time of engraftment, and 3 of 9 patients had persistence of the marker gene for greater than 18 months posttransplantation. The marker gene was detected in multiple lineages, including granulocytes, T cells, and B cells. The source of the marking was both the transduced PB graft and the BM graft, with a suggestion of better long-term marking originating from the PB graft. The steady-state levels of marking were low, with only 1:1000 to 1:10,000 cells positive. There was no toxicity noted, and patients did not develop detectable replication-competent helper virus at any time posttransplantation. These results suggest that mobilized PB cells may be preferable to BM for gene therapy applications and that progeny of mobilized peripheral blood cells can contribute long-term to engraftment of multiple lineages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Basic Science of Gene Therapy
Mulligan, R. C. (1993) · Science · doi:10.1126/science.8493530 · Cited by 1,741
Miller, A. D., & Buttimore, C. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2895 · Cited by 1,370
Human gene therapy comes of age
Miller, A. D. (1992) · Nature · doi:10.1038/357455a0 · Cited by 908
Miller, D. G., Adam, M. A., & Miller, A. D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.8.4239 · Cited by 893
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
Brenner, M. K., Rill, D. R., Krance, R. A., Ihle, J. N., Moen, R. C., Mirro, J., & Anderson, W. F. (1993) · The Lancet · doi:10.1016/0140-6736(93)92560-g · Cited by 893
Self-citationHelper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer
Donahue, R. E., Kessler, S. W., Bodine, D., McDonagh, K., Dunbar, C., Goodman, S., Agricola, B., Byrne, E., Raffeld, M., & Moen, R. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.4.1125 · Cited by 532
Self-citationEngraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma
Berenson, R., Bensinger, W., Hill, R., Andrews, R., Garcia-Lopez, J., Kalamasz, D., Still, B., Spitzer, G., Buckner, C., & Bernstein, I. (1991) · Blood · doi:10.1182/blood.v77.8.1717.1717 · Cited by 519
Self-citationSelection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1
Sorrentino, B. P., Brandt, S. J., Bodine, D., Gottesman, M., Pastan, I., Cline, A., & Nienhuis, A. W. (1992) · Science · doi:10.1126/science.1352414 · Cited by 477
Deisseroth, A., Zu, Z., Claxton, D., Hanania, E., Fu, S., Ellerson, D., Goldberg, L., Thomas, M., Janicek, K., & Anderson, W. (1994) · Blood · doi:10.1182/blood.v83.10.3068.3068 · Cited by 462
Rill, D., Santana, V., Roberts, W., Nilson, T., Bowman, L., Krance, R., Heslop, H., Moen, R., Ihle, J., & Brenner, M. (1994) · Blood · doi:10.1182/blood.v84.2.380.380 · Cited by 406
Self-citation
Cited by
Transfer of Genes to Humans: Early Lessons and Obstacles to Success
Crystal, R. G. (1995) · Science · doi:10.1126/science.270.5235.404 · Cited by 1,000
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA − Immunodeficient Patients
Bordignon, C., Notarangelo, L. D., Nobili, N., Ferrari, G., Casorati, G., Panina, P., Mazzolari, E., Maggioni, D., Rossi, C., Servida, P., et al. (1995) · Science · doi:10.1126/science.270.5235.470 · Cited by 832
Larochelle, A., Vormoor, J., Hanenberg, H., Wang, J. C. Y., Bhatia, M., Lapidot, T., Moritz, T., Murdoch, B., Xiao, X. L., Kato, I., et al. (1996) · Nature Medicine · doi:10.1038/nm1296-1329 · Cited by 726
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Lyman, S. D., & Jacobsen, S. E. W. (1998) · Blood · doi:10.1182/blood.v91.4.1101 · Cited by 696
The Biology and Clinical Uses of Blood Stem Cells
To, L. B., Haylock, D. N., Simmons, P. J., & Juttner, C. A. (1997) · Blood · doi:10.1182/blood.v89.7.2233 · Cited by 689
Metadata
- Authors
- Dunbar, C., Cottler-Fox, M., O'Shaughnessy, J., Doren, S., Carter, C., Berenson, R., Brown, S., Moen, R., Greenblatt, J., & Stewart, F.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1995-06-01
- Volume
- 85
- Issue
- 11
- Pages
- 3048-3057
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2305289606
- Cited by
- 449
- References
- 31
- FWCI
- 31.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. https://app.cochat.ai/papers/10.1182/blood.v85.11.3048.bloodjournal85113048
- The paper
- Dunbar, C., Cottler-Fox, M., O'Shaughnessy, J., Doren, S., Carter, C., Berenson, R., Brown, S., Moen, R., Greenblatt, J., & Stewart, F. (1995). Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. https://doi.org/10.1182/blood.v85.11.3048.bloodjournal85113048
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.